GRTS

Gritstone bio (GRTS)

About Gritstone bio (GRTS)

Gritstone bio, Inc. clinical-stage biotechnology company, which engages in developing the next generation of cancer immunotherapies to fight multiple cancer types. The company was founded by Andrew Allen, Timothy Chan, Mark Cobbold, Graham Lord, Naiyer Rizvi and Jean-Charles Soria in August 2015 and is headquartered in Emeryville, CA.

Details

Daily high

$0.21

Daily low

$0.19

Price at open

$0.20

52 Week High

$3.33

52 Week Low

$0.18

Market cap

22.4M

Dividend yield

0.00%

Volume

4.7M

Avg. volume

4.0M

P/E ratio

-.16

Gritstone bio News